On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
On Mar. 12, 2020, Innovation Pharma announced research procedures that one of the 12 Regional Biocontainment Labs (RBLs)…
On Mar. 12, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
On Mar. 12, 2020, Chembio Diagnostics announced it has entered into a worldwide strategic partnership with LumiraDx Limited…
On Mar. 11 2020, the World Health Organization declared the Coronavirus outbreak a global pandemic. To-date, of the…
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
On Mar. 11, 2020, the Howard Hughes Medical Institute (HHMI) announced the Medically Trained Scientists Program (MTS), an…
On Mar. 11, 2020, bioMerieux announced the forthcoming launch of 3 different tests to address the COVID-19 epidemic…
On Mar. 11, 2020, Vir Biotech announced a research collaboration agreement with the NIH to advance characterization and…
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
On Mar. 10, 2020, the Bill & Melinda Gates Foundation, Wellcome, and Mastercard committed up to $125 million…
On Mar. 10, 2020, ImmunityBio announced results from studies evaluating N-803, an IL-15 superagonist, alone and in combination…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
On Mar. 9, 2020, the FDA approved Boehringer Ingelheim’s Ofev (nintedanib) oral capsules to treat patients with chronic…
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
On Mar. 9, 2020, MediciNova announced that it planned to initiate development of MN-166 (ibudilast) for severe pneumonia…
On Mar. 9, 2020, Humanigen announced that it was actively exploring clinical stage strategies and partnerships to evaluate…
On Mar. 9, 2020, Winship Cancer Institute’s multiple myeloma team was awarded a $5 million grant from The…
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
On Mar. 8, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
On Mar. 8, 2020, an international team of investigators reported finding a protein produced by the human immune…
On Mar. 6, 2020, the FDA approved Isturisa (osilodrostat) oral tablets for adults with Cushing’s disease who either…
On Mar. 6, 2020, the Government of Canada announced an investment of nearly $27 million to fund Coronavirus…
On Mar. 6, 2020, University of British Columbia (UBC) researchers Yue Qian, Dr. Richard Lester, Dr. Srinivas Murthy,…